MEDBOT-B (02252) has announced the receipt of approval from the Stock Exchange of Hong Kong, dated February 13, 2026, for the listing and trading of 5.9898 million H-shares. These shares, which are to be converted and listed, represent the total number of non-listed shares involved. The conversion and listing will pertain to an aggregate of 5.9898 million non-listed shares held by two of the company's shareholders, accounting for approximately 0.5808% of the company's total issued share capital as of the announcement date.